title: Intravenous iron and vertical HIV transmission: any connection?
authors.affiliation: aNorthampton General Hospital NHS Trust bNorthamptonshire Healthcare NHS Foundation Trust, Cliftonville, Northampton cGuy's and St Thomas' NHS Foundation Trust dImperial College Healthcare NHS Trust, St Mary's Hospital, London eMRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK. *Hal Drakesmith and Hermione Lyall contributed equally to the writing of this article.
authors.forename: Fiona
authors.initials: F
authors.lastname: Thompson
authors.forename: Mohamed
authors.initials: M
authors.lastname: Ghanem
authors.forename: Katie
authors.initials: K
authors.lastname: Conway
authors.forename: Annemiek
authors.initials: A
authors.lastname: de Ruiter
authors.forename: Graham P
authors.initials: GP
authors.lastname: Taylor
authors.forename: Hal
authors.initials: H
authors.lastname: Drakesmith
authors.forename: Hermione
authors.initials: H
authors.lastname: Lyall
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D005260:Female; D015658:HIV Infections / Q000517:prevention & control*; D015497:HIV-1 / Q000302:isolation & purification*; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D008297:Male; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*
chemical_list: D019380:Anti-HIV Agents